Eversept Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-30,195
| Closed | -$10.6M | – | 132 |
|
|
2025
Q4 | $10.6M | Sell |
30,195
-14,785
| -33% | -$5M | 0.53% | 48 |
|
|
2025
Q3 | $14.5M | Buy |
44,980
+26,018
| +137% | +$8.09M | 1% | 24 |
|
|
2025
Q2 | $7.38M | Buy |
18,962
+3,264
| +21% | +$1.31M | 0.68% | 36 |
|
|
2025
Q1 | $6.83M | Sell |
15,698
-13,480
| -46% | -$5.41M | 0.69% | 33 |
|
|
2024
Q4 | $10.8M | Buy |
29,178
+9,713
| +50% | +$4.06M | 0.96% | 25 |
|
|
2024
Q3 | $10.1M | Buy |
19,465
+4,808
| +33% | +$2.57M | 0.69% | 29 |
|
|
2024
Q2 | $7.94M | Buy |
14,657
+264
| +2% | +$140K | 0.54% | 31 |
|
|
2024
Q1 | $7.46M | Sell |
14,393
-701
| -5% | -$349K | 0.5% | 37 |
|
|
2023
Q4 | $7.12M | Sell |
15,094
-6,600
| -30% | -$3.05M | 0.63% | 33 |
|
|
2023
Q3 | $9.45M | Buy |
21,694
+19,379
| +837% | +$8.79M | 0.8% | 26 |
|
|
2023
Q2 | $1.03M | Sell |
2,315
-18,300
| -89% | -$8.44M | 0.09% | 62 |
|
|
2023
Q1 | $9.48M | Sell |
20,615
-7,427
| -26% | -$3.53M | 0.66% | 31 |
|
|
2022
Q4 | $14.4M | Sell |
28,042
-4,998
| -15% | -$2.54M | 1.26% | 18 |
|
|
2022
Q3 | $15M | Sell |
33,040
-9,745
| -23% | -$4.66M | 1.3% | 17 |
|
|
2022
Q2 | $20.6M | Buy |
42,785
+10,334
| +32% | +$5.11M | 1.47% | 17 |
|
|
2022
Q1 | $15.9M | Sell |
32,451
-1,843
| -5% | -$842K | 1.22% | 26 |
|
|
2021
Q4 | $15.9M | Buy |
34,294
+2,666
| +8% | +$1.12M | 1.02% | 28 |
|
|
2021
Q3 | $11.8M | Buy |
31,628
+21,496
| +212% | +$8.17M | 0.82% | 34 |
|
|
2021
Q2 | $3.87M | Sell |
10,132
-53,760
| -84% | -$20.5M | 0.26% | 53 |
|
|
2021
Q1 | $22.9M | Sell |
63,892
-1,879
| -3% | -$604K | 1.72% | 22 |
|
|
2020
Q4 | $21.1M | Buy |
+65,771
| New | +$20.2M | 2.48% | 16 |
|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$3.02M | – | 67 |
|
|
2019
Q4 | $3.02M | Buy |
+10,000
| New | +$2.75M | 0.53% | 36 |
|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$2.82M | – | 61 |
|
|
2019
Q2 | $2.82M | Buy |
+10,000
| New | +$2.73M | 0.79% | 30 |
|
|
2019
Q1 | – | Sell |
-2,300
| Closed | -$604K | – | 54 |
|
|
2018
Q4 | $604K | Hold |
2,300
| – | – | 0.33% | 40 |
|
|
2018
Q3 | $630K | Sell |
2,300
-2,700
| -54% | -$701K | 0.28% | 47 |
|
|
2018
Q2 | $1.19M | Sell |
5,000
-1,000
| -17% | -$232K | 0.54% | 40 |
|
|
2018
Q1 | $1.32M | Buy |
+6,000
| New | +$1.41M | 0.61% | 31 |
|
Other funds holding ELV
VCM
VPM
Eversept Partners's ELV Position: Q1 2026 in Review
Eversept Partners sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 30,195 shares — an estimated $10.6M sold.
Eversept Partners first reported a position in ELV in Q1 2018 and held it in 27 quarters. The position peaked at $22.9M in Q1 2021. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Eversept Partners reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Eversept Partners sold 30,195 Elevance Health shares in Q1 2026, an estimated $10.6M.
- Eversept Partners first reported a position in Elevance Health in Q1 2018 and held it in 27 quarters.
- Eversept Partners's Elevance Health position peaked at $22.9M in Q1 2021.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.